ARS Pharmaceuticals, Inc. (SPRY) - Ekuitas Perusahaan

Logo perusahaan publik ARS Pharmaceuticals, Inc. (SPRY)

This daily price chart for SPRY shows indicators at 0.01, while ARS Pharmaceuticals has developed a unique nasal adrenaline for treating allergic shocks. The company is investing in needle-free delivery methods and scientific research. Its competitive advantage is secured by patents for a comfortable spray that is displacing traditional injectable devices.

SPRY Kapitalisasi Buku ARS Corp (28.04.2023 - 27.10.2026)

Rincian metrik lan analitis perusahaan ARS Pharmaceuticals, Inc. (SPRY)

- rega lan prakiraan konsensus rega:
Bagan owah-owahan rega ARS Corp|SPRY - Target konsensus
- data kapitalisasi pasar:
Nilai pasar ARS Pharmaceuticals Inc|SPRY - Nilai Total Perusahaan
- data kapitalisasi buku:
Nilai Buku Saham ARS Pharmaceuticals|SPRY - Kapitalisasi Buku|Nilai Pasar marang Nilai Buku ars-pharma.com|SPRY - Total Aset Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal ARS Pharmaceuticals|SPRY - Utang jangka dawa marang ekuitas|Rasio tanggungan utang jangka cendhak marang modal ARS Pharmaceuticals Inc|SPRY - Utang perusahaan|Utang marang nilai buku ARS Pharmaceuticals Inc
Pambiji fundamental:SPRY - ARS Corp
Barang unggulan ARS Pharmaceuticals Inc

Book value reflects the net value of the company's assets minus all liabilities. This metric demonstrates the speed at which operating profit is converted into real capital. By analyzing the firm's book value history, an investor can quickly detect hidden resource erosion. For ARS Pharmaceuticals (SPRY), this indicator confirms financial stability during the implementation of its innovative nasal spray. Capital growth here enables the scaling of a product that replaces traditional injections.

Analisis pesaing ARS Pharmaceuticals

Haleon Corp (HLN) - Nilai Akuntansi Perusahaan|Aset Bersih Perusahaan KVUE|VRNA (veronapharma.com) - Ekuitas Perusahaan|Nilai Buku Perusahaan Jyong Biotech MENS|Nilai Aset Bersih Ligand Pharmaceuticals Incorporated|Amneal Pharmaceuticals Inc (AMRX) - Kapitalisasi Buku|Nilai Akuntansi Perusahaan Perrigo Corp (PRGO)|Kapitalisasi Buku ALVO (Alvotech)|liquidia.com - Kapitalisasi Buku|Nilai Buku Perusahaan Galapagos (GLPG)|ANIP: Nilai Akuntansi Perusahaan|MNKD (MannKind Corp.) - Nilai Buku Perusahaan|Amphastar Corp (AMPH) - Aset Bersih Perusahaan|PCRX (Pacira BioSciences) - Kapitalisasi Buku|Kapitalisasi Buku theravance.com (TBPH)|Aquestive Therapeutics, Inc. (AQST) - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan SCPH (scpharmaceuticals.com)|TECX: Nilai Buku Perusahaan|TNXP - Ekuitas Perusahaan|Aset Bersih Perusahaan SXT China SXTC|EPRX - Total Aset Bersih|Kapitalisasi Buku BioHarvest Sciences Inc. BHST|Invizyne Technologies (EXOZ) - Nilai Akuntansi Perusahaan|Kapitalisasi Buku ORMP (Oramed)|Ekuitas Perusahaan ENTX|MindWalk Holdings (HYFT) - Nilai Buku Perusahaan|Nilai Akuntansi Perusahaan abvcpharma.com (ABVC)|Kapitalisasi Buku CPIX (Cumberland Pharmaceuticals Inc.)|Quantum BioPharma Ltd. - Kapitalisasi Buku|Nilai Buku Perusahaan FibroGen Corp (FGEN)|TELO: Nilai Akuntansi Perusahaan|ranitherapeutics.com - Nilai Buku Perusahaan|Pambiji Buku Bisnis Synergy CHC|RLYB - Aset Bersih Perusahaan|Nilai Akuntansi Perusahaan LEXX|PULM - Nilai Buku Perusahaan|Nilai Aset Bersih ftzy.com.cn (PTHL)|Kapitalisasi Buku Aptorum Group|Nilai Akuntansi Perusahaan lyratherapeutics.com LYRA|Impact BioMedical Inc - Kapitalisasi Buku|TNFA: Kapitalisasi Buku|Nilai Buku Perusahaan cbdmd.com YCBD|PRFX (PainReform Corp) - Nilai Akuntansi Perusahaan|Nilai Buku Perusahaan CYTO|Aset Bersih Perusahaan lipella.com|Kapitalisasi Buku OPTN|Kapitalisasi Buku Pieris Pharmaceuticals Inc (PIRS)|Procaps Group SA - Kapitalisasi Buku|Aset Bersih Perusahaan Petros Pharma PTPI|QLI (Qilian International) - Kapitalisasi Buku|acelyrin.com (SLRN) - Ekuitas Perusahaan|TFFP: Aset Bersih Perusahaan